Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada, operating through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments, alongside both basic and advanced dental technology and equipment. Additionally, it provides practice optimization solutions such as practice management software, e-commerce, revenue cycle management, and patient engagement systems. The segment also includes a range of related services, comprising software and design services, maintenance and repair, and equipment financing. In the Animal Health segment, the company distributes an array of biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, both prescription and non-prescription diets, nutritional products, consumable supplies, equipment, and software, coupled with value-added services. Furthermore, this segment features a private label portfolio of products for veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment provides customer financing services and sells various miscellaneous products. The company serves a diverse clientele, including dentists, laboratories, institutions, veterinarians, and animal health product retailers. Financially, the company incurred an income tax expense of $57,534,000.00 indicating its tax obligations. The weighted average number of diluted shares outstanding is 93,679,000.00 reflecting potential dilution effects. With an operating income ratio of 0.04 the company showcases its operational profitability margin. It reported an income before tax of $243,053,000.00 highlighting its pre-tax profitability, while the gross profit stands at $1,380,242,000.00 underscoring profitability from core operations. In terms of investment potential, the stock is affordable at $31.33 making it suitable for budget-conscious investors. Additionally, the stock has a high average trading volume of 1,454,898.00 indicating strong liquidity. With a mid-range market capitalization of $2,771,884,154.00 Patterson Companies, Inc. positions itself as a steady performer within the marketplace. As a key player in the Medical - Distribution industry, the company contributes significantly to the overall market landscape and belongs to the Healthcare sector, consistently driving innovation and growth in its respective fields.